Our study not only concurs with previous studies showing a link between ERCC1 overexpression and chemoresistance but also provides additional insight suggesting that ERCC1 may also be involved in the emergence of aggressive breast cancer phenotypes. This evidence concerns the gene ERCC1 and breast cancer.